| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Edgewise Therapeutics, Inc. (EWTX) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. EWTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 262.5K | $9.27M | - | |
| Other | 105.0K | $3.71M | - | |
| Dir | 45.1K | $1.59M | - | |
| CEO | 38.6K | $1.36M | - | |
| Dir | 30.0K | $1.06M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 20, 2024 | Donovan Joanne M.49 | CMO | Sell | 7,162 | $28.29 | $202,602.95 | -33.0% | +8.9% | -49.6% | |
| Sep 20, 2024 | Derakhshan Behrad52 | Chief Business Officer | Sale+OE | 42,068 | $29.03 | $1,221,133.08 | -73.6% | +8.9% | -49.6% | |
| Sep 20, 2024 | Carruthers R Michael48 | Chief Financial Officer | Sale+OE | 125,092 | $28.57 | $3,573,979.93 | -60.5% | +8.9% | -49.6% | |
| May 2, 2024 | Moore John R45 | General Counsel | Sale+OE | 1,956 | $18.91 | $36,987.96 | -37.6% | -11.7% | -12.3% | |
| May 2, 2024 | Carruthers R Michael48 | Chief Financial Officer | Sale+OE | 2,157 | $18.91 | $40,788.87 | -5.8% | -11.7% | -12.3% | |
| May 2, 2024 | Derakhshan Behrad52 | Chief Business Officer | Sale+OE | 1,718 | $18.91 | $32,487.38 | -11.3% | -11.7% | -12.3% | |
| May 2, 2024 | Russell Alan J77 | Chief Scientific Officer | Sale+OE | 1,576 | $18.91 | $29,802.16 | -17.9% | -11.7% | -12.3% | |
| May 2, 2024 | Donovan Joanne M.49 | CMO | Sale+OE | 3,682 | $18.91 | $69,626.62 | -15.6% | -11.7% | -12.3% | |
| May 2, 2024 | Koch Kevin55 | President And CEO | Sale+OE | 3,152 | $18.91 | $59,604.32 | -17.9% | -11.7% | -12.3% | |
| Feb 9, 2024 | Derakhshan Behrad52 | Chief Business Officer | Sale+OE | 10,000 | $20.03 | $200,258.04 | -32.2% | +2.7% | +35.4% |